Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03602079 |
Title | Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Klus Pharma Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Florida Cancer Specialists & Research Institute | Sarasota | Florida | 34232 | United States | Details | |
Beth Israel Deaconess Medical Center Cancer Center | Boston | Massachusetts | 02215 | United States | Details | |
Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
Clinical Research Alliance, Inc. | Lake Success | New York | 11042 | United States | Details | |
Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
Providence Cancer Institute | Portland | Oregon | 97213 | United States | Details | |
Mary Crowley Cancer Research Centers - Medical City | Dallas | Texas | 75230 | United States | Details | |
The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
South Texas Accelerated Research Therapeutics, LLC (START) | San Antonio | Texas | 78229 | United States | Details | |
Virginia Cancer Specialist | Fairfax | Virginia | 22031 | United States | Details |